HCV core and NS3 proteins manipulate human blood-derived dendritic cell development and promote Th 17 differentiation

International Immunology

Volumn 24, Issue 2, 2012, Pages 97-106

  Tu, Zhengkun ^a,b   Hamalainen laanaya, Heli K ^a   Nishitani, Chiaki ^c   Kuroki, Yoshio ^c   Crispe, Ian Nicholas ^d   Orloff, Mark S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Guangzhou Eighth People's Hospital   (China)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Antiviral responses; Immune subversion; Innate immunity; Programmed death ligand; Toll like receptor

Indexed keywords

CD14 ANTIGEN; CD1B ANTIGEN; CD209 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; NONSTRUCTURAL PROTEIN 3; T6 ANTIGEN; VIRUS PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; DENDRITIC CELL; HEPATITIS C VIRUS; HEPATITIS C VIRUS CORE; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CORE;

EID: 84856565842     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr104     Document Type: Article

References (33)

1. Kanto, T. and Hayashi, N. 2006. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity. Intern. Med. J. 45:183.
2. Rehermann, B. 2007. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin. Liver Dis. 27:152.
3. Szabo, G. and Dolganiuc, A. 2005. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection. Immunobiology 210:237.
4. Kanto, T., Hayashi, N., Takehara, T. et al. 1999. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 162:5584.
5. Auffermann-Gretzinger, S., Keeffe, E. B. and Levy, S. 2001. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 97:3171.
6. Ormandy, L. A., Farber, A., Cantz, T. et al. 2006. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J. Gastroenterol. 12:3275.
7. Bain, C., Fatmi, A., Zoulim, F., Zarski, J. P., Trepo, C. and Inchauspe, G. 2001. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 120:512.
8. Dolganiuc, A., Kodys, K., Kopasz, A., Marshall, C., Mandrekar, P. and Szabo, G. 2003. Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction alcohol. Clin. Exp. Res. 27:1023.
9. Yakushijin, T., Kanto, T., Inoue, M. et al. 2006. Reduced expression and functional impairment of toll-like receptor 2 on dendritic cells in chronic hepatitis C virus infection. Hepatol. Res. 34:156.
10. Kakumu, S., Ito, S., Ishikawa, T. et al. 2000. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J. Gastroenterol. Hepatol. 15:431.
11. Longman, R. S., Talal, A. H., Jacobson, I. M., Albert, M. L. and Rice, C. M. 2004. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103:1026.
12. Rollier, C., Drexhage, J. A., Verstrepen, B. E. et al. 2003. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment. Hepatology 38:851.
13. Dolganiuc, A., Oak, S., Kodys, K. et al. 2004. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513.
14. Li, K., Foy, E., Ferreon, J. C. et al. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the tolllike receptor 3 adaptor protein TRIF. Proc. Natl Acad. Sci. USA 102:2992.
15. Hsieh, T. Y., Matsumoto, M., Chou, H. C. et al. 1998. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleo protein K. J. Biol. Chem. 273:17651.
16. Tu, Z., Pierce, R. H., Kurtis, J., Kuroki, Y., Crispe, I. N. and Orloff, M. S. 2010. Hepatitis C virus core protein subverts the anti-viral activities of human kupffer cells. Gastroenterology 138:305.
17. Iwaki, D., Mitsuzawa, H., Murakami, S. et al. 2002. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J. Biol. Chem. 277:24315.
18. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor a. J. Exp. Med 179:1109.
19. Tu, Z., Bozorgzadeh, A., Crispe, I. N. and Orloff, M. S. 2007. The activation state of human intrahepatic lymphocytes. Clin. Exp. Immunol. 149:186.
20. Tu, Z., Bozorgzadeh, A., Pierce, R. H., Kurtis, J., Crispe, I. N. and Orloff, M. S. 2008. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205:233.
21. Dolganiuc, A., Chang, S., Kodys, K. et al. 2006. Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection. J. Immunol. 177:6758.
22. Allavena, P., Piemonti, L. and Longoni, D. 1998. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28:359.
23. Shen, T., Chen, X., Chen, Y., Xu, Q., Lu, F. and Liu, S. 2010. Increased PD-L1 expression and PD-L1/CD86 ratio on dendritic cells were associated with impaired dendritic cells function in HCV infection. J. Med. Virol. 82:1152.
24. Pachiadakis, I., Chokshi, S., Cooksley, H. et al. 2009. Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions. Clin. Immunol. 131:415.
25. Rutella, S., Danese, S. and Leone, G. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108:1435.
26. Dolganiuc, A., Paek, E., Kodys, K., Thomas, J. and Szabo, G. 2008. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes. Gastroenterology 135:2119.
27. Thumann, C., Schvoerer, E., Abraham, J. D. et al. 2008. Hepatitis C virus structural proteins do not prevent human dendritic cell maturation. Gastroenterol. Clin. Biol. 32:59.
28. Wilson, N. J., Boniface, K., Chan, J. R. et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950.
29. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. and Sallusto, F. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942.
30. van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W. et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660.
31. Wei, L., Laurence, A., Elias, K. M. and O'Shea, J. J. 2007. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282:34605.
32. Basha, H. I., Subramanian, V., Seetharam, A. et al. 2011. Characterization of HCV-Specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am. J. Transplant. 11:775.
33. Zhang, J. Y., Zhang, Z., Lin, F. et al. 2010. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51:81.